The slip
PARKINSON RECEIPTno. 14084
29 Oct 2026, 12:29 UTColigodendrocytes, braak
predictionFAM221A in oligodendrocytes tracks Braak Lewy-body stage
registeredddbf98ad332d794e
discovery-0.21 p=0.591 n=9
replication-0.19 p=0.630 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.21, p 0.591)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTe5989d4fbb5c73721d778789…
follows 6102e0bbf6ce…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 14084: FAM221A in oligodendrocytes, braak
- power
- full sample -0.23 (p 0.360, n 18), 95% CI -0.63 to +0.27. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.23 (p 0.360, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.28 (p 0.254, n 18). could be the mix.
- skeptic
- leave-one-out range -0.41 to -0.12, sign flips 0; without severely affected donors -0.23 (p 0.360, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for FAM221A in oligodendrocytes.
case closed: nothing better to follow up.